No country resorts to IVF more than Japan—or has less success
By The Economist,
The Economist
| 05. 26. 2018
The sterile façade of Kato Ladies Clinic gives little hint of the fecundity inside. Nestling among a plantation of high-rises in a business district of Tokyo, the clinic implants fertilised eggs in an average of 75 women a day. That makes it one of the busiest fertility hospitals in the world, says Keiichi Kato, the medical director.
Japan has come a long way since journalists were warned off the taboo story of Princess Masako’s visits to fertility clinics 20 years ago. The wife of the crown prince, then in her late thirties, was being nudged to produce an heir to the throne (in the end, she disappointed traditionalists by having a girl). Today Japan has less than half America’s population, but more than a third more hospitals and clinics that offer fertility treatment. Over 50,000 babies were born last year with the help of in vitro fertilisation (IVF)—5% of all births.
Nearly a fifth of Japanese couples struggle to have children, says the health ministry. Women are postponing marriage; social pressures mean there are far fewer babies born out of...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...